文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

比较自膨胀瓣膜与球囊扩张瓣膜在升主动脉扩张患者接受经导管主动脉瓣置换术中的随机对照试验方案(AAD-CHOICE)

Protocol for a randomized controlled trial for comparison of self- and balloon-expandable valves in patients with Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement (AAD-CHOICE).
PubMed 文献 · Trials · 2025-11-28

AAD-CHOICE是一项多中心、随机对照、开放标签试验,计划将100例升主动脉扩张(升主动脉直径≥45 mm)接受经导管主动脉瓣置换术的患者按1:1随机分入自膨胀瓣膜组或球囊扩张瓣膜组,随访至少1年,主要终点为器械成功、30天全因死亡和30天不良主动脉事件。

要点

  • 针对升主动脉扩张(直径≥45 mm)接受经导管主动脉瓣置换术的患者,比较自膨胀瓣膜与球囊扩张瓣膜。
  • 计划随机分配100例患者,1:1分组,随访至少1年。
  • 主要终点为器械成功、30天全因死亡和30天不良主动脉事件。

核心结论

  • 该研究将为升主动脉扩张患者接受经导管主动脉瓣置换术时自膨胀瓣膜与球囊扩张瓣膜的表现提供证据。

研究设计与样本

  • AAD-CHOICE试验为多中心、随机对照、开放标签研究。
  • 计划随机分配100例升主动脉扩张(升主动脉直径≥45 mm)接受经导管主动脉瓣置换术的患者,按1:1比例分入自膨胀瓣膜组或球囊扩张瓣膜组。
  • 参与者随访至少1年。

关键数值与推荐

  • 主要终点为器械成功、30天全因死亡和30天不良主动脉事件。
  • 关键次要终点为1年全因死亡、1年心血管死亡、不良主动脉事件、主要不良心脑血管事件和主动脉扩张速率≥3 mm/年。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Self-expandable valves (SEVs) and balloon-expandable valves (BEVs) are the most widely used transcatheter heart valves. In patients with ascending aortic dilation (AAD) who undergo transcatheter aortic valve replacement (TAVR), comparison of two type of valves is lacking. METHODS: The AAD-CHOICE trial is a multi-center, randomized controlled, open-label study. The trial will randomly assign 100 patients with AAD (ascending aortic diameter ≥ 45 mm) who undergo TAVR in 1:1 ratio to either SEV group or BEV group. Participants will be followed for a minimum of 1 year. The primary end point is device success, 30-day all-cause mortality and 30-day adverse aortic events. The key secondary end point is 1-year all-cause mortality, 1-year cardiovascular mortality, adverse aortic events, major adverse cardiovascular and cerebrovascular events, and aortic expansion rate ≥ 3 mm/year. DISCUSSION: The study will provide evidence regarding the performance of SEVs and BEVs in patients with AAD who undergo TAVR. TRIAL REGISTRATION: ClinicalTrials.gov NCT06009588. Registered on August 12, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. An K, Zhang F, Ouyang W, et al. Protocol for a randomized controlled trial for comparison of self- and balloon-expandable valves in patients with Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement (AAD-CHOICE). Trials. 2025. PMID: 41316413. doi:10.1186/s13063-025-09233-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。